When was RenalGuard Solutions founded?

RenalGuard Solutions was founded in 1981 and raised its 1st funding round 30 years after it was founded.

Where is RenalGuard Solutions located?

RenalGuard Solutions is headquartered in Milford, United States.

How many employees does RenalGuard Solutions have?

As of Mar 31, 2026, the latest employee count at RenalGuard Solutions is 37.

Is RenalGuard Solutions a funded company?

RenalGuard Solutions is a funded company, having raised an undisclosed amount across 7 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Mar 07, 2011.

When was the latest funding round of RenalGuard Solutions?

RenalGuard Solutions' latest funding was a $***** Post IPO round on Mar 16, 2017, with participation from 2 investors. Its primary sector is Nephrology. In United States, the Nephrology sector has seen $158M in funding in 2026 to date.

Where does RenalGuard Solutions rank among its competitors?

RenalGuard Solutions ranks 4th amongst 7 active competitors, only 1 of which is funded. Lowell Therapeutics, which secured $1M in Nov, 2021.

Who are the top competitors of RenalGuard Solutions?

RenalGuard Solutions' top competitors include Sentien Biotechnologies, GE Global Research and NorrDia AB. Among them, Lowell Therapeutics secured the most recent funding round in November, 2021.

RenalGuard Solutions - 2026 Company Profile, Funding & Competitors

RenalGuard Solutions is a late stage company based in Milford (United States), founded in 1981. It operates as an Innovating AKI prevention with fluid management technology for multiple clinical settings. RenalGuard Solutions has raised an undisclosed amount in funding. The company has 7 active competitors, including 1 that is funded. Its top competitors include companies like Sentien Biotechnologies, GE Global Research and NorrDia AB.

Company Details

Innovating AKI prevention with fluid management technology for multiple clinical settings. The company develops and markets a clinically proven solution for preventing acute kidney injury (AKI) using its proprietary RenalPro system. This system autonomously bundles fluid management and therapeutic systems, integrating into clinical workflows to maintain hemodynamic stability and prevent over- or under-hydration. The technology addresses AKI in cardiac surgery, contrast-associated procedures, and ICU patients. The company aims to improve patient outcomes, reduce healthcare costs, and enhance the quality of life through its innovations. The company focuses on medical devices, fluid management, renal care, and patient monitoring.

Website: renalguard.com
Social

Key Metrics

Founded Year

1981

Location

Milford, United States

Stage

Late Stage

Latest Funding Round

Post IPO, Mar 16, 2017, $*****

Investors

Exigent Capital Group & 2 more

Ranked

4^th among 7 active competitors

Employee Count

37 as on Mar 31, 2026

Similar Companies

Sentien Biotechnologies & 10 more

View RenalGuard Solutions' full profile

RenalGuard Solutions is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
RENALGUARD SOLUTIONS, INC CIN: 941252 , United States, Active	Jul 18, 1982	-	-	-

RenalGuard Solutions has raised funding over 7 rounds. Its first funding round was on Mar 07, 2011. Its latest funding round was a Post IPO round on Mar 16, 2017 for $*****. 2 investors participated in its latest round. RenalGuard Solutions has 3 institutional investors.

Here is the list of recent funding rounds of RenalGuard Solutions:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 16, 2017	1869783	Post IPO	4764138	6540388	9033646	9657737
Jun 10, 2014	1883264	Post IPO	3315200	5313474	3209443	9421072
Jun 04, 2014	2560093	Post IPO	7093369	3045114	4936245	1076899

Access funding benchmarks and valuations. Sign up today!

View details of RenalGuard Solutions's funding rounds and investors

RenalGuard Solutions' employee count trend

RenalGuard Solutions has 37 employees as of Mar 26. Here is RenalGuard Solutions's employee count trend over the years:

Employee count trend for RenalGuard Solutions

Uncover RenalGuard Solutions' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RenalGuard Solutions include Sentien Biotechnologies, GE Global Research and NorrDia AB. Here is the list of Top 10 competitors of RenalGuard Solutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sentien Biotechnologies 2008, Lexington (United States), Series A	Developer of stem cell based device product for acute organ failure	$13M	Boehringer Ingelheim Venture Fund, Mission BioCapital ... & 6 others	45/100
2nd	GE Global Research 1900, China, Funding Raised	Developer of renal bio-replacement therapy for compromised kidney function treatment	-	-	36/100
3rd	NorrDia AB Unfunded	Developer of medical devices for the treatment of renal care	-	-	32/100
4th	RenalGuard Solutions 1981, Milford (United States), Late Stage	Innovating AKI prevention with fluid management technology for multiple clinical settings	-	Exigent Capital Group, Bantam Group & 1 others	32/100
5th	Sonogenix Belmont (United States), Unfunded	Developer of non-invasive device for acute and chronic kidney disease	-	-	24/100
6th	Renamed Bio 1995, Waltham (United States), Deadpooled	Developer of renal bio-replacement therapy for compromised kidney function treatment	$40M	-	24/100
7th	Lowell Therapeutics 2018, Lowell (United States), Acqui-Hired	Developer of anticoagulant for the treatment of acute kidney diseases	$1M	Kyto Technology & Life Science	19/100
8th	3ive Labs 2018, Roswell (United States), Unfunded	Developer of devices to restore kidney function	-	-	19/100
9th	CardioRenal Systems Milford (United States), Funding Raised	Manufacturer of medical devices for fluid management and kidney protection	-	Kidron Capital	15/100
10th	EndoVentions 2019, San Rafael (United States), Deadpooled	Developer of devices for treating kidney stones	-	-	14/100